Coya Therapeutics (COYA) Return on Sales (2023 - 2026)

Coya Therapeutics (COYA) has 4 years of Return on Sales data on file, last reported at 0.29% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales changed 0.0% year-over-year to 0.29%; the trailing twelve-month figure through Mar 2026 stood at 0.03% (up 5.0% YoY), and the FY2025 full-year result was 0.03%, up 2.0% from the prior year.
• Return on Sales declined to 0.29% in Q1 2026, from 0.02% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2023 to a low of 62.55% in Q4 2024.
• A 4-year average of 6.4% and a median of 0.15% in 2025 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales sank 6254 bps in 2024 and surged 6253 bps in 2025, its largest moves.
• Tracing COYA's Return on Sales over 4 years: stood at 0.01% in 2023, then sank by 985280 bps to 62.55% in 2024, then jumped by 100 bps to 0.02% in 2025, then plunged by 1226 bps to 0.29% in 2026.
• Business Quant data shows COYA's Return on Sales at 0.29% in Q1 2026, 0.02% in Q4 2025, and 0.01% in Q3 2025.